Hosted on MSN3h
Nurse's Death Tied to GLP-1 Drug; Research Monkey Jailbreak; Congressman Has Cancer
Diabetes and weight-loss drug tirzepatide (Mounjaro, Zepbound) was listed as a contributing factor in the death of a ...
Hosted on MSN7h
GLP-1 Drug Shortage Is Over. Why Might These Drugs Soon Be Costlier and Harder to Access?
In October, the FDA removed Mounjaro and Zepbound—the diabetes and obesity GLP-1 drugs made by Eli Lilly—from the shortage ...
Eli Lilly Just Hit a Milestone That Disappointed. Here's Why You Should Still Buy the Stock.
Even a juggernaut like Eli Lilly ( LLY 2.71%) can miss the mark sometimes. When it reported its third-quarter earnings on Oct. 30, its share price plunged to the tune of 11% before recovering somewhat ...
AOL18h
Investors Like Certainty. Trump's Win Gave Them Some.
Why Novo Nordisk and Eli Lilly are giving totally different reads on the markets for GLP-1 drugs like Wegovy and Zepbound. To catch full episodes of all The Motley Fool's free podcasts, check out our ...